Lifeline Biotechnologies Stock Performance
| LLBO Stock | USD 0.0006 0.0001 20.00% |
On a scale of 0 to 100, Lifeline Biotechnologies holds a performance score of 2. The company secures a Beta (Market Risk) of -0.66, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Lifeline Biotechnologies are expected to decrease at a much lower rate. During the bear market, Lifeline Biotechnologies is likely to outperform the market. Please check Lifeline Biotechnologies' total risk alpha and the relationship between the potential upside and day typical price , to make a quick decision on whether Lifeline Biotechnologies' current price movements will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Lifeline Biotechnologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental drivers, Lifeline Biotechnologies displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Lifeline |
Lifeline Biotechnologies Relative Risk vs. Return Landscape
If you would invest 0.09 in Lifeline Biotechnologies on November 6, 2025 and sell it today you would lose (0.03) from holding Lifeline Biotechnologies or give up 33.33% of portfolio value over 90 days. Lifeline Biotechnologies is currently generating 0.498% in daily expected returns and assumes 15.4807% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Lifeline, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lifeline Biotechnologies Target Price Odds to finish over Current Price
The tendency of Lifeline Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0006 | 90 days | 0.0006 | about 87.53 |
Based on a normal probability distribution, the odds of Lifeline Biotechnologies to move above the current price in 90 days from now is about 87.53 (This Lifeline Biotechnologies probability density function shows the probability of Lifeline Pink Sheet to fall within a particular range of prices over 90 days) .
Lifeline Biotechnologies Price Density |
| Price |
Predictive Modules for Lifeline Biotechnologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lifeline Biotechnologies. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Lifeline Biotechnologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lifeline Biotechnologies is not an exception. The market had few large corrections towards the Lifeline Biotechnologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lifeline Biotechnologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lifeline Biotechnologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.47 | |
β | Beta against Dow Jones | -0.66 | |
σ | Overall volatility | 0.0001 | |
Ir | Information ratio | 0.03 |
Lifeline Biotechnologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lifeline Biotechnologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lifeline Biotechnologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lifeline Biotechnologies had very high historical volatility over the last 90 days | |
| Lifeline Biotechnologies has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (574.27 K) with profit before overhead, payroll, taxes, and interest of 0. |
Lifeline Biotechnologies Fundamentals Growth
Lifeline Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Lifeline Biotechnologies, and Lifeline Biotechnologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lifeline Pink Sheet performance.
| Current Valuation | 4.25 M | |||
| Cash And Equivalents | 603.32 K | |||
| Total Debt | 448.07 K | |||
| Debt To Equity | 0.08 % | |||
| Book Value Per Share | 0 X | |||
| Total Asset | 6.72 M | |||
About Lifeline Biotechnologies Performance
By examining Lifeline Biotechnologies' fundamental ratios, stakeholders can obtain critical insights into Lifeline Biotechnologies' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Lifeline Biotechnologies is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada. Lifeline Biotech operates under Medical Devices classification in the United States and is traded on OTC Exchange.Things to note about Lifeline Biotechnologies performance evaluation
Checking the ongoing alerts about Lifeline Biotechnologies for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Lifeline Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lifeline Biotechnologies had very high historical volatility over the last 90 days | |
| Lifeline Biotechnologies has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (574.27 K) with profit before overhead, payroll, taxes, and interest of 0. |
- Analyzing Lifeline Biotechnologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lifeline Biotechnologies' stock is overvalued or undervalued compared to its peers.
- Examining Lifeline Biotechnologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lifeline Biotechnologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lifeline Biotechnologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lifeline Biotechnologies' pink sheet. These opinions can provide insight into Lifeline Biotechnologies' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Lifeline Pink Sheet
Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.